The DNA helicase HELQ promotes replication fork reversal in coordination with BRCA2- and FANCD2-mediated repair pathways
Nucleic Acids Research · 23.04.2026 · 54 (8)
DOI: 10.1093/nar/gkag332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 29.04.2026. Verfasst von Yerkin Dunbayev und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea. Hauptthemen laut MEDLINE: DNA Replication, Fanconi Anemia Complementation Group D2 Protein, DNA Helicases, BRCA2 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institute for Basic Science, NCI NIH HHS, National Taiwan University.
Abstract (Originalsprache)
HELQ is a 3′–5′ DNA helicase whose loss sensitizes cells to DNA-damaging agents, particularly DNA crosslinkers. HELQ interacts with the RAD51 paralog complex RAD51B–RAD51C–RAD51D–XRCC2 (BCDX2), a key mediator of replication fork reversal. Using DNA fiber assays, we show that HELQ and BCDX2 act epistatically to slow replication fork progression under replication stress. Because fork reversal transiently regresses nascent strands into a four-way junction and reduces net DNA synthesis, this fork slowing provides a functional readout of fork reversal. Directly supporting this model, electron microscopy reveals that reversed fork structures are reduced in HELQ-knockout cells. Consistent with a role in fork reversal, HELQ deletion suppresses nascent strand degradation when BRCA2- or FANCD2-dependent fork protection is lost. Mechanistically, biochemical reconstitution shows that HELQ is stimulated by RPA on fork substrates containing a leading strand gap, and these findings are consistent with the cell-based DNA fiber assays. Together, these results identify HELQ as a specialized regulator of replication fork remodeling that promotes fork reversal through the BCDX2 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Genomic Integrity, Institute for Basic Science, Ulsan 44919, Republic of Korea.
- Department of Biological Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea.
- Institute of Biochemical Sciences, National Taiwan University, Taipei 10617, Taiwan.
- Department of Oncology and Hematology-Oncology, University of Milan, Via Adamello 16, Milan 20139, Italy.
- IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan 20139, Italy.
- Division of Pharmacology and Toxicology, College of Pharmacy, The University of Texas at Austin, Dell Pediatric Research Institute, 1400 Barbara Jordan Boulevard, Austin, TX 78723, United States.
ORCID-Profile: Peter Chi, Kei-Ichi Takata
Förderung
- Institute for Basic Science
- NCI NIH HHS
- National Taiwan University
- National Science and Technology Council
- National Cancer Institute
Zitieren
APA
Dunbayev, Y., Chen, Y. J., Sassi, L., Lee, E. A., Ra, J. S., Choi, M., Mukherjee, A., Vasquez, K. M., Costanzo, V., Chi, P., & Takata, K. I. (2026). The DNA helicase HELQ promotes replication fork reversal in coordination with BRCA2- and FANCD2-mediated repair pathways. Nucleic Acids Research, 54(8). https://doi.org/10.1093/nar/gkag332
Vancouver
Dunbayev Y, Chen YJ, Sassi L, Lee EA, Ra JS, Choi M, et al. The DNA helicase HELQ promotes replication fork reversal in coordination with BRCA2- and FANCD2-mediated repair pathways. Nucleic Acids Research. 2026;54(8). doi:10.1093/nar/gkag332
BibTeX
@article{Dunbayev2026,
author = {Dunbayev, Yerkin and Chen, Yen-Ju and Sassi, Lorenzo and Lee, Eun A and Ra, Jae Sun and Choi, Moonjung and Mukherjee, Anirban and Vasquez, Karen M and Costanzo, Vincenzo and Chi, Peter and Takata, Kei-Ichi},
title = {The DNA helicase HELQ promotes replication fork reversal in coordination with BRCA2- and FANCD2-mediated repair pathways},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {8},
doi = {10.1093/nar/gkag332}
}
EUVIMED